期刊文献+

The Relationship of PSA,PSAD and Clinicopathological Stage in Patients with Prostate Cancer

The Relationship of PSA,PSAD and Clinicopathological Stage in Patients with Prostate Cancer
下载PDF
导出
摘要 OBJECTIVE To investigate the relationship between the clinicopatho- logical stage and serum prostate specific antigen(PSA)concentration and PSAdensity(PSAD)in patients with prostate cancer. METHODS The clinicopathological stage was determined on the basis of a pathological examination and clinical data in 65 prostate cancer patients treated by radical prostatectomy.PSA and PSAD were measured before the operation.The Spearman rank correlation was applied to evaluate the relationship between the clinicopathological stage,serum PSAconcentration and PSAD. RESULTS Patients with higher PSA and PSAD were significantly more likely to have higher clinical stages,a higher Gleason score,positive surgical margins,capsular penetration,and seminal vesicle invasion(each P<0.05). But there was no significant association between PSA and lymph node metastasis(P=0.053).The levels of serum PSA concentration and PSAD were significantly correlated with the clinical stage(P<0.05)in the prostate cancer patients. CONCLUSION The level of both PSA and PSAD were significantly correlated with the clinical stage(P<0.05)in the prostate cancer patients.But PSAD may be a more powerful predictor of clinical stage and prognosis than PSA. OBJECTIVE To investigate the relationship between the clinicopathological stage and serum prostate specific antigen (PSA) concentration and PSA density (PSAD) in patients with prostate cancer. METHODS The clinicopathological stage was determined on the basis of a pathological examination and clinical data in 65 prostate cancer patients treated by radical prostatectomy. PSA and PSAD were measured before the operation. The Spearman rank correlation was applied to evaluate the relationship between the clinicopathological stage, serum PSA concentration and PSAD. RESULTS Patients with higher PSA and PSAD were significantly more likely to have higher clinical stages, a higher Gleason score, positive surgical margins, capsular penetration, and seminal vesicle invasion (each P〈0.05). But there was no significant association between PSA and lymph node metastasis (P=0.053). The levels of serum PSA concentration and PSAD were significantly correlated with the clinical stage (P〈0.05) in the prostate cancer patients. CONCLUSION The level of both PSA and PSAD were significantly correlated with the clinical stage (P〈0.05) in the prostate cancer patients. But PSAD may be a more powerful predictor of clinical stage and prognosis than PSA.
机构地区 Department of Urology
出处 《Chinese Journal of Clinical Oncology》 CSCD 2007年第5期318-321,共4页 中国肿瘤临床(英文版)
关键词 前列腺 癌症 治疗方法 抗原 prostate cancer, prostate specific antigen,prostate specific antigen density
  • 相关文献

参考文献10

  • 1Catalona WJ,Southwick PC,Slawin KM,et al.Compari-son of percent free PSA,PSA density,and age-specificPSA cutoffs for prostate cancer detection and staging[].Urology.2000
  • 2Datta MW,Dhir R,Dobbin K,et al.Prostate cancer inpatients with screening serum prostate specific anti-gen values less than 4.0 ng/ml:results from the co-operative prostate cancer tissue resource[].Journal d Urologie.2005
  • 3Stamey TA,Caldwell M,McNeal JE,et al.The prostatespecific antigen era in the United States is over forprostate cancer:what happened in the last 20 years[].The Journal of Urology.2004
  • 4Noguchi M,Stamey TA,Neal JE,et al.An analysisof 148 consecutive transition zone cancers:clini-cal and histological characteristics[].Journal d Urologie.2000
  • 5Aleman M,Karakiewicz PI,Kupelian P,et al.Age andPSA predict likelihood of organ-confined disease inmen presenting with PSA less than 10 ng/ml:implica-tions for screening[].Urology.2003
  • 6Freeland SJ,Kane CJ,Presti JC,et al.Comparison ofpreoperative prostate specific antigen density andprostate specific antigen for predicting recurrence af-ter radical prostatectomy:results from the search database[].Journal d Urologie.2003
  • 7Sozen S,Eskicorapci S,Kupeli B,et al.Complexedprostate specific antigen density is better than theother PSA derivatives for detection of prostate can-cer in men with total PSA between 2.5 and 20 ng/ml:results of a prospective multicenter study[].EuropeanUrology.2005
  • 8Ohi M,Ito K,Suzuki K,et al.Diagnostic significanceof PSA density adjusted by transition zone volume inmales with PSA levels between 2 and 4 ng/ml[].Euro-pean Urology.2004
  • 9Stamey TA,Johnstone IM,McNeal JE,et al.Preopera-tive serum prostate specific antigen levels between2 and 22 ng/ml correlate poorly with post-radicalprostatectomy cancer morphology:prostate specificantigen cure rates appear constant between 2 and 9ng/ml[].Journal d Urologie.2002
  • 10Benson MC,Whang IS,Pantuck A,et al.Prostate spe-cific antigen density:a means of distinguishing benignprostate hypertrophy and prostate cancer[].Journal d Urologie.1992

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部